Gynecologic Oncology · 2017 · 76 citations · 27 references
MedicineCancer BiologyOncologyGynecologic OncologyMolecular OncologyTumor ProgressionMalignant NeoplasmsOncogenic Signaling PathwaysOvarian CancerOvarian DisordersOvarian NeoplasiaOvarian PathologyMalignant Ovarian NeoplasmsMalignant Ovarian TumorsOvarian Cancer BiomarkersOvarian Cancer PathogenesisOvarian Cancer Prognostic BiomarkersOvarian Tumor BiomarkersOvarian Tumor Grading
27
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations
Medicine, Immunology, Oncology +17
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel et al. · New England Journal of Medicine · 2006 · 2.6K citations · Full text
Medicine, Gynecology, Oncology +14
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text
Medicine, Gynecology, Oncology +11
Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations
Medicine, Gynecology, Oncology +17